Jan 10, 2022 / 06:30PM GMT
Tycho W. Peterson - JPMorgan Chase & Co, Research Division - Senior Analyst
Good afternoon. I'm Tycho Peterson. It's my pleasure to introduce our next company today, Adaptive Biotechnologies. Just a quick reminder, if people have questions or submit question function on the website. And with that, I'll turn it over to Chad.
Chad M. Robins - Adaptive Biotechnologies Corporation - Co-Founder, CEO & Chairman
Thank you, Tycho, and thanks for the opportunity to present at JPMorgan and also Happy New Year to you.
So welcome, everyone, to the Adaptive Biotechnologies' presentation. We are the leading company in harnessing the power of the Adaptive immune system, and we're going to do so in a number of important ways, which I'm excited to share with you today. Throughout the pandemic, the world got a crash course in the adaptive immune system and the role that T cells play in fighting disease. We saw countless publications and articles highlighting the relevance of antibodies and of T cells in immunity. At Adaptive, that's exactly what we're focused on
Adaptive Biotechnologies Corp at JPMorgan Healthcare Conference Transcript
Jan 11, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers